US Stock MarketDetailed Quotes
CABA Cabaletta Bio
- 3.820
- +0.810+26.91%
Close Nov 29 13:00 ET
- 3.980
- +0.160+4.18%
Post 17:01 ET
186.71MMarket Cap-1768P/E (TTM)
4.600High3.610Low17.98MVolume3.800Open3.010Pre Close72.21MTurnover43.25%Turnover RatioLossP/E (Static)48.88MShares26.35052wk High1.07P/B158.78MFloat Cap1.76052wk Low--Dividend TTM41.57MShs Float26.350Historical High--Div YieldTTM32.89%Amplitude0.590Historical Low4.017Avg Price1Lot Size
Cabaletta Bio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -61.24%-20.32M | -74.86%-20.79M | -90.26%-23.99M | -15.46%-53.55M | -35.59%-16.45M | -27.13%-12.6M | -3.15%-11.89M | 1.57%-12.61M | -35.98%-46.38M | -15.37%-12.13M |
| Net income from continuing operations | -86.22%-30.63M | -90.53%-27.6M | -57.99%-25.05M | -27.75%-67.68M | -33.10%-20.89M | -43.94%-16.45M | -12.22%-14.49M | -22.46%-15.85M | -14.44%-52.98M | -12.99%-15.69M |
| Depreciation and amortization | 19.44%424K | 15.14%426K | 7.67%393K | 21.05%1.43M | -6.15%336K | -2.20%355K | 55.46%370K | 66.67%365K | 60.71%1.18M | 52.99%358K |
| Other non cash items | 241.03%2M | 251.35%1.96M | 191.73%1.62M | -18.54%2.48M | --780K | --585K | --557K | --556K | --3.04M | ---- |
| Change In working capital | 428.83%2.9M | 96.77%-31K | -2,808.45%-4.13M | 102.35%101K | 147.70%654K | 204.18%548K | -72.17%-959K | 92.30%-142K | -177.03%-4.3M | -189.14%-1.37M |
| -Change in prepaid assets | 197.24%528K | -6.36%604K | -198.99%-394K | -3,081.25%-954K | -20,671.43%-1.45M | -59.24%-543K | 124.74%645K | 327.96%398K | -98.75%32K | 99.04%-7K |
| -Change in payables and accrued expense | 126.26%4.44M | 123.31%217K | -4,067.39%-1.83M | 483.76%4.66M | 151.69%3.58M | 525.38%1.96M | -7.75%-931K | 103.51%46K | -139.32%-1.21M | -38.09%1.42M |
| -Change in other current assets | 23.33%-230K | 211.54%116K | -4,018.75%-659K | -450.00%-1.14M | -683.87%-724K | -208.70%-300K | -620.00%-104K | 97.45%-16K | -258.62%-208K | 475.76%124K |
| -Change in other current liabilities | -222.28%-1.84M | -70.12%-968K | -119.65%-1.25M | 15.60%-2.46M | 74.33%-747K | ---570K | ---569K | ---570K | ---2.91M | ---2.91M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -61.24%-20.32M | -74.86%-20.79M | -90.26%-23.99M | -15.46%-53.55M | -35.59%-16.45M | -27.13%-12.6M | -3.15%-11.89M | 1.57%-12.61M | -35.98%-46.38M | -15.37%-12.13M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 18,941.54%12.25M | 149.29%23.73M | -103.30%-812K | 17.51%-22.45M | 459.49%1.14M | -100.27%-65K | -5,261.02%-48.14M | 149.33%24.62M | -553.69%-27.22M | -137.22%-316K |
| Net PPE purchase and sale | -289.23%-253K | -1,250.88%-770K | -113.68%-812K | 71.99%-687K | 41.46%-185K | 94.05%-65K | 93.65%-57K | -158.50%-380K | -110.38%-2.45M | -109.27%-316K |
| Net investment purchase and sale | --12.5M | 150.95%24.5M | --0 | 12.11%-21.76M | --1.32M | --0 | ---48.09M | 150.24%25M | -445.62%-24.76M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 18,941.54%12.25M | 149.29%23.73M | -103.30%-812K | 17.51%-22.45M | 459.49%1.14M | -100.27%-65K | -5,261.02%-48.14M | 149.33%24.62M | -553.69%-27.22M | -137.22%-316K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -27.55%71K | -99.60%379K | 2,933.19%6.86M | 468.89%187.63M | 182.90%93.05M | 98K | 235,545.00%94.26M | 343.14%226K | -32.56%32.98M | 141.35%32.89M |
| Net common stock issuance | --0 | --0 | 2,576.72%5.75M | 463.70%185.2M | 179.22%91.74M | ---141K | --93.84M | ---232K | -31.91%32.86M | 142.60%32.86M |
| Proceeds from stock option exercised by employees | -70.29%71K | -10.19%379K | 142.14%1.11M | 1,812.60%2.43M | 3,538.89%1.31M | --239K | 955.00%422K | 798.04%458K | -80.46%127K | -57.65%36K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -27.55%71K | -99.60%379K | 2,933.19%6.86M | 468.89%187.63M | 182.90%93.05M | --98K | 235,545.00%94.26M | 343.14%226K | -32.56%32.98M | 141.35%32.89M |
| Net cash flow | ||||||||||
| Beginning cash position | 39.46%178.61M | 86.79%175.29M | 136.79%193.24M | -33.23%81.61M | 88.84%115.5M | 171.52%128.07M | 57.58%93.85M | -33.23%81.61M | 20.50%122.22M | -48.28%61.16M |
| Current changes in cash | 36.32%-8.01M | -90.30%3.32M | -246.63%-17.95M | 374.85%111.63M | 280.24%77.74M | -189.83%-12.57M | 376.38%34.23M | 119.53%12.24M | -295.33%-40.62M | 416.00%20.44M |
| End cash Position | 47.71%170.61M | 39.46%178.61M | 86.79%175.29M | 136.79%193.24M | 136.79%193.24M | 88.84%115.5M | 171.52%128.07M | 57.58%93.85M | -33.23%81.61M | -33.23%81.61M |
| Free cash flow | -62.41%-20.58M | -80.47%-21.56M | -90.95%-24.8M | -11.06%-54.24M | -33.63%-16.63M | -15.11%-12.67M | 3.85%-11.95M | -0.25%-12.99M | -38.44%-48.83M | -16.70%-12.45M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
